We have previously shown that proliferation of the estrogen-receptor-positive MCF7 and T47D, and the ErbB2-overexpressing JIMT-1, SKBR3 and BT474 breast tumor cell lines is decreased following treatment with sFRP1 [7]. The gene discussed is ERBB2; the disease is breast neoplasm.